Nephro Care India IPO: Deepak Parekh-backed company plans to raise ₹41.26 cr through public issue

Nephro Care India Ltd is set to launch its initial public offer to raise ₹41.26 crore on Friday, June 28. The Kolkata-based healthcare firm operates a comprehensive treatment centre in the city, offering various clinical and lifestyle solutions.

Nephro Care India IPO offer size

Nephro Care India IPO is a book-built issue valued at ₹41.26 crore. The IPO consists of a fresh issue of 45.84 lakh shares and there is no offer for sale (OFS) portion. The company has reserved 50% of the net issue size for Qualified Institutional Buyers. Retail investors and non-institutional investors (NIIs) have been allocated 35% and 15% of the net issue respectively.

Nephro Care India IPO lot size and minimum investment

The price band for Nephro Care India IPO has been fixed in the range of ₹85 to ₹90 per share. Retail investors interested in applying for Nephro Care India IPO can bid for a minimum of 1 lot or 1600 shares, aggregating to an investment of ₹1,44,000. High Networth Investors can bid for the issue with a minimum of 2 lots or 3,200 shares, totalling ₹2,88,000 at the upper price band.

Nephro Care India IPO subscription, allotment status and listing date

The subscription window for the Nephro Care India IPO will remain open from June 28 to July 2. The finalisation of share allotment in the IPO is scheduled to be completed by Wednesday, July 3.

This will be followed by the credit of shares into the demat account of successful bidders, and the initiation of refunds for non-allottees in the IPO will be done on Thursday, July 4.

Shares offered in Nephro Care India IPO are likely to be listed on the NSE’s SME platform on Friday, July 5.

Nephro Care India Limited IPO financials

Nephro Care India IPOs generated revenue of ₹19.89 crore for the 9-month period that ended on December 31, 2023. The company earned a Profit After Tax (PAT) of ₹3.4 crore. In the same period, the net worth stood at ₹13.92 crore

The company’s revenue for FY23 increased nearly 400% to ₹17.09 crore compared to ₹3.42 crore in the preceding fiscal. The PAT grew to ₹1.94 crore in the year ended March 31, 2023, from a loss of ₹98 lakh in the year-ago period. Nephro Care India’s net worth for FY23 stood at ₹2.43 crore.

Nephro Care India Limited IPO registrar

The registrar for Nephro Care India Limited IPO is Bigshare Services Pvt Ltd, while Corporate Capital Ventures Pvt Ltd is the book-running lead manager for the issue. SS Corporate Securities Ltd is the market maker for the issue.

Nephro Care India Limited promoters

Promoter Pratim Sengupta holds an 85.02% pre-issue stake in the company which will be diluted to 61.39% post the IPO.

Nephro Care India Limited IPO objective

Money raised through the public issue will be used by Nephro Care India Limited to set up a multi-speciality hospital, Vivacity Multi Specialty Hospital, in Kolkata.

A part of the proceeds will also be used for general corporate purposes.

About Nephro Care India Limited

Nephro Care India Limited was incorporated in 2014 and is a comprehensive treatment centre located in Kolkata. The treatment centre offers a wide range of clinical and lifestyle solutions.

The treatment centre provides healthcare services to nearly 900 chronic kidney disease patients every month. As of March 31, 2024, Nephro Care India Limited employed 110 people in various departments.

To know more about IPOs listing, schedule and upcoming IPOs, click here